John Restaino

Background

About John Restaino

Dr. John Restaino, attorney-at-law, podiatric surgeon and epidemiologist by training, is licensed in California, based out of CO and practices across the country. He is an Associate Adjunct Professor at the University of South Carolina College of Pharmacy, Department of Clinical Pharmacy and Outcomes Sciences, Columbia, S. C. Dr. Restaino has earned his reputation as the primary ‘go to’ attorney when the litigation involves complex scientific, medical, epidemiological and legal issues. He has chaired or co-chaired the Expert and Science Committees for many of the federal MultiDistrict Litigations (MDLs) of the past 20 years including the Diet Pill litigation, Rezulin, Zyprexa, Vioxx, Yaz/Yasmin oral contraceptives, Ortho-Evra Contraceptive Patch, the Gadolinium Contrast Agent Litigation, the DePuy ASR Hip Prosthesis litigation, the Lipitor/diabetes in women litigation and the Incretins/pancreatic cancer litigation. Currently, Dr. Restaino is 'the tip of the spear' in developing the science behind the fluoroquinolone antibiotics and aortic aneurysms and dissection and the association between proton pump inhibitors and gastric and/or pancreatic cancer. Dr. Restaino enjoys unparalleled recognition by plaintiff and defense lawyers for his expertise in complex scientific and medical aspects of litigation and is widely recognized and respected by scientific and medical experts across the globe. Dr. Restaino is widely sought after as a lecturer on medical and epidemiological topics and their applicability to the law. As a trial lawyer, Dr. Restaino is recognized for his ability to make the ‘complex sound simple’ as he talks with jurors during Open Statements and Closing Arguments and for his skills in cross-examining defense medical and scientific experts. Specialties: Complex medical, scientific and epidemiological aspects of litigation.